"Noze Raises $5M for Breath-Based Diagnostics, Focuses on Low-Income Countries"

Noze Secures Funding for Breath-Based Diagnostics

Noze, a leader in breath-based diagnostics, recently secured a $5 million equity investment from the Bill & Melinda Gates Foundation, bringing their total contributions to $6.8 million. With their innovative handheld diagnostic breathalyzer, DiagNoze®, Noze aims to improve healthcare access and disease detection in low and middle-income countries. They are seeking partnerships with research institutions, manufacturing and supply chain solutions, and marketing firms to further develop and distribute their technology.

Funding Amount: $5 million

Industry: Non-profit Organizations

Employee Count: 1001-5000

CEO: Bill Gates (CEO Linkedin)

What Noze needs to buy: Noze is looking for partnerships with research institutions, manufacturing and supply chain solutions, and marketing firms. Companies in the healthcare, medical device manufacturing, and marketing industries are ideal partners for Noze to further develop and distribute their breath-based diagnostic technology, DiagNoze®, and expand their reach in low and middle-income countries.